Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5

Cell(2024)10.1016/j.cell.2024.06.037Source: DataRank Database

Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5 is a research paper published in Cell (2024). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Download PDF

Cite:

Linked data & code

gen cellosaurus nct pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)OA: hybridTopics (44)IDs (PubMed, PMC)Annotations (4)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (37)

Andrew J. R. Cooper ORCID,Brendan Farrell ORCID,Kazutoyo Miura ORCID,Ababacar Diouf ORCID,Nicole Müller ORCID

Live enrichment

PubMed:39059381 PMC:PMC11383431

USAID

Grant: GH-BAA-2018-Addendum03

Wellcome Trust

Grant: 220797/Z/20/Z

Wellcome Trust

Grant: 206194

Wellcome Trust Sanger Institute - generic account for deposition of all core- funded research papers.

Wellcome Trust

Grant: 209200/Z/17/Z

Wellcome Trust

Grant: 106917/Z/15/Z

Wellcome Trust

Grant: 106917

Harnessing Human Antibodies to Deliver Effective Immunoprophylaxis against Difficult Disease Targets.

Wellcome Trust

Grant: 220797

Erythrocyte invasion in malaria: molecular mechanism to precision therapeutics

Wellcome Trust

Grant: 209200

The impact of vaccine platform on the cellular drivers of humoral immunity

National Institute of Allergy and Infectious Diseases

Silver Family Foundation

U.S. Department of Health and Human Services

Vaccine Research Center

National Institutes of Health

National Institute of Allergy and Infectious Diseases Division of Intramural Research

Wellcome Trust

hybridLicense: cc-by

publisherhttps://doi.org/10.1016/j.cell.2024.06.037

publisherhttps://api.elsevier.com/content/article/PII:S0092867424007116?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0092867424007116?httpAccept=text/plain

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11383431/pdf/main.pdf

Europe_PMChttps://europepmc.org/articles/PMC11383431

Fields of Study

03 medical and health sciences0303 health sciences

MeSH Terms

B-LymphocytesHumansPlasmodium falciparumMalaria, FalciparumImmunoglobulin GCarrier ProteinsProtozoan ProteinsMalaria VaccinesAntibodies, MonoclonalAntibodies, ProtozoanAntigens, ProtozoanEpitopesAdolescentAdultMaliFemaleMaleAntibodies, Neutralizing

Keywords

Monoclonal antibodiesMalariaPlasmodium falciparumVaccine designnatural infectionRh5AdultMaleAdolescentProtozoan ProteinsAntibodies, ProtozoanAntigens, ProtozoanMaliArticleEpitopesMalaria VaccinesHumansMalaria, FalciparumB-LymphocytesAntibodies, MonoclonalAntibodies, NeutralizingImmunoglobulin GFemaleCarrier Proteins

Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5

FAIR Checklist

Authors (37)

Funding (15 grants)

Open Access

Topics

Annotations (Europe PMC)